Abstract | Dendritic cells (DCs) are crucial for the generation and the regulation of adaptive immunity. Because DCs have a pivotal role in marshalling immune responses, HIV has evolved ways to exploit DCs, thereby facilitating viral dissemination and allowing evasion of antiviral immunity. Defining the mechanisms that underlie cell-cell transmission of HIV and understanding the role of DCs in this process should help us in the fight against HIV infection. This Review highlights the latest advances in our understanding of the interactions between DCs and HIV, focusing on the mechanisms of DC-mediated viral dissemination.
, so the fight against HIV infection and transmission has some way to go. Heterosexual trans mission is the main route of dissemination of HIV infection worldwide and accounts for 80% of HIV infections 1, 2 . Because dendritic cells (DCs) are located in the mucosae (including the oral and vaginal mucosal surfaces) and the lymphoid tissues, they have been proposed to be among the first cells that encounter HIV type 1 (HIV-1; referred to as HIV from this point) during sexual transmission. It has also been suggested that DCs mediate the spread of HIV to CD4 + T cells in the lymphoid tissues in vivo. CD4 + T cells are the main source of HIV replication and dissemination (reviewed in (FIG. 1) . So, hopefully, understanding the mechanisms of the interactions of HIV with DCs and cellular factors will facilitate the development of more-effective interventions against HIV infection and transmission and might aid in the development of novel strategies for the design of vaccines against HIV infection.
It has been known for more than a decade that HIV-pulsed DCs facilitate viral infection of co-cultured T cells 6, 7 . Recent studies of DC-HIV interactions have highlighted an important role for DCs in HIV transmission at mucosal surfaces and in HIV pathogenesis. These studies have also revealed several potential mechanisms that underlie DC-mediated HIV transmission. One reported route for viral transfer is across the 'infectious synapse' (also known as the virological synapse), which is formed between DCs and T cells 8, 9 . Another recently identified pathway indicates that trans-infection with HIV might also be mediated by DC-derived exosomes 10 . Alternatively, HIV-infected DCs might transmit infection in cis [11] [12] [13] [14] [15] . Further studies of the significance and relative contributions of these pathways to viral transmission in vivo might shed light on HIV pathogenesis.
This Review focuses on the interactions of HIV with different subsets of DCs, outlining the potential mechanisms of viral dissemination and the relevance to viral pathogenesis.
DC subsets and interactions with HIV
One of the enigmatic features of DC biology is the complexity of DC subsets. Unlike other immune cells, DCs can have either a myeloid or a lymphoid origin 16, 17 . DCs are also relatively rare in both the blood and the tissues. DCs can be classified into several subsets on the basis of their anatomical distribution, immunological function and cell-surface-marker expression. These properties, as well as their susceptibility to HIV infection and their capacity to disseminate viral infection, are summarized in TABLE 1 for each of the main DC subsets.
DC subsets in vivo.
The main DC subsets include myeloid DCs and plasmacytoid DCs (pDCs) in the blood, and Langerhans cells in the tissues (TABLE 1) . Myeloid DCs and pDCs are present at low frequencies, together constituting 0.5-2% of total peripheral-blood mononuclear cells 17, 18 . In general, myeloid DCs are characterized by their ability to secrete large amounts of interleukin-12 (IL-12), whereas pDCs can prime antiviral adaptive immune responses by producing large 
Trans-infection
Monocyte-derived dendritic cells and certain types of cell that have been transfected with vectors that encode DC-SIGN (DC-specific intercellular adhesion molecule 3 (ICAM3)-grabbing non-integrin) can capture and transfer HIV to target cells without themselves becoming infected. amounts of type I interferons (IFNs) 19, 20 . Langerhans cells are mainly found in the skin and the stratified squamous epithelia; they constitute 2-3% of epidermal cells 16, 21 . These DCs express langerin (also known as CD207), a Langerhans-cell-specific C-type lectin 22 .
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HIV
DC subsets and HIV infection. Myeloid DCs, pDCs and
Langerhans cells are all susceptible to infection with HIV 11, 21, [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] . They all express relatively small amounts of the HIV receptor CD4 and the HIV co-receptors CC-chemokine receptor 5 (CCR5), CXC-chemokine receptor 4 (CXCR4), CCR3, CCR8, CCR9 and CXCR6 (also known as BONZO and STRL33) [34] [35] [36] [37] [38] . Although both myeloid DCs and pDCs are susceptible to laboratory-adapted R5 HIV strains and X4 HIV strains, myeloid DCs are more susceptible to infection with these R5 HIV strains than are pDCs from the same donor 33 . In addition, R5 HIV strains infect myeloid DCs much more efficiently than do X4 HIV strains, probably because myeloid DCs express more CCR5 than CXCR4 (REFS 11, 21, 28, 31, 33) .
Compared with HIV replication in CD4
+ T cells, HIV replication in DCs is generally less productive 4, 11, 28, 29, 31, 39, 40 , and the frequency of HIV-infected DCs in vivo is often 10-to 100-fold lower 41 . A study of cells from healthy donors indicated that, on average, only 1-3% of the myeloid DC population and of the pDC population can be productively infected with HIV in vitro, as detected by intracellular staining of the HIV capsid protein 33 . A similarly low frequency has been reported for in vitro HIV infection of Langerhans cells isolated from healthy individuals 11 . The reasons that are presumed to explain this moderate HIV infection of DCs include the following: low levels of expression of the HIV receptor and co-receptors by DCs, rapid and extensive degradation of internalized HIV in intracellular compartments of DCs 12, 13, 42 , and expression of a host factor(s) that blocks HIV replication. An example of such a host factor is the antiretroviral protein APOBEC3G, which has been shown to block HIV replication in resting CD4 + T cells and might be an important innate immune component that prevents retroviral infection 43 . Nevertheless, further investigation is required to improve our understanding of how DCs restrict productive HIV infection.
Follicular DCs as reservoirs of HIV. Follicular DCs (FDCs) are not considered to be typical DCs, because they are not derived from the bone marrow and are not known to process and present antigens using MHCrestricted pathways 16, 44 . Usually, FDCs are found only in the B-cell follicles and germinal centres of the peripheral lymphoid tissues. FDCs have the unique capacity to trap pathogens, including HIV, and retain infectious viruses for long periods 45, 46 . FDCs can trap and maintain large quantities of HIV early after infection, thereby establishing an insidious reservoir of infectious virus proximal to CD4 + T cells, which are highly susceptible to infection, in the lymphoid tissues 47, 48 . Notably, FDCs are not productively infected by HIV; instead, FDCs harbour a large and relatively stable pool of virions at their surface 45, 46, 49, 50 . In addition, FDCs can promote the migration of resting CD4 + T cells to the germinal-centre microenvironment, and this might further facilitate the infection of CD4 + T cells, thereby contributing to HIV pathogenesis 46, 50 . In addition to FDCs, HIV-infected DCs might function as viral reservoirs, enabling persistent infection in vivo. A recent study reported that productive viral replication occurred in HIV-infected monocyte-derived DCs (MDDCs) for up to 45 days 51 . However, it remains to be determined whether DCs can provide a cellular reservoir for latent infection and whether they could be potential targets for eradication of HIV.
MDDCs as an in vitro model. Owing to the low abundance of DCs in vivo, MDDCs are commonly used to model the immunological function of DCs and to study DC-HIV interactions in experimental studies in vitro 4, 52 . DC-associated HIV might be protected intracellularly from degradation during the migration of these cells or during their retention in the lymphoid tissues. Some DC subsets are susceptible to HIV infection, and they subsequently infect neighbouring CD4 + T cells. Follicular DCs (FDCs), which reside in germinal centres, can trap large amounts of HIV at their surface, and this provides a stable 'hideaway' for HIV and also facilitates dissemination of HIV.
C-type lectins
A family of transmembrane proteins (with calciumdependent activities) that function as cell-adhesion molecules. C-type lectins are involved in the regulation of signalling pathways and recognize specific carbohydrate structures of pathogens and self antigens.
R5 HIV
An HIV strain that uses CC-chemokine receptor 5 (CCR5) as the co-receptor to gain entry to target cells.
X4 HIV
An HIV strain that uses CXCchemokine receptor 4 (CXCR4) as the co-receptor to gain entry to target cells.
CD14
+ monocytes from human peripheral blood differentiate into immature DCs after 4-6 days in culture in the presence of IL-4 and granulocyte/macrophage colony-stimulating factor. These immature MDDCs have similar characteristics to myeloid DCs, immature dermal DCs and interstitial DCs, and they express large amounts of the cell-surface markers CD11c, CD25, DC-specific intercellular adhesion molecule 3 (ICAM3)-grabbing non-integrin (DC-SIGN; also known as CD209) and MHC class II molecules 53 . Immature MDDCs can be converted into mature MDDCs by exposure to various stimuli, including lipopolysaccharide, IFNγ (type II IFN), tumour-necrosis factor and CD40 ligand 16, 44, 54 (FIG . 2) . It has been observed that using different stimuli to promote DC maturation might result in the generation of DCs with distinct capacities for transmitting HIV 55 . Despite the convenience of using MDDCs, these cells do not fully mimic the immunological function of the DC subsets that are involved in HIV infection in vivo 36, [56] [57] [58] . Therefore, experimental observations that are made using MDDCs, and the physiological conclusions that are drawn from such studies, should be interpreted carefully. For example, C-type lectins expressed at the surface of MDDCs account for more than 80% of the binding to the HIV envelope glycoprotein gp120; however, freshly isolated and cultured peripheral-blood DCs bind gp120 only through CD4 and not through C-type lectins 36 . So, although MDDCs have provided insights into the biology of DCs and into DC-HIV interactions, examining HIV capture and transmission by bona fide DC subsets in vivo, and studying the antigen-processing pathways of these DCs, would benefit our understanding of the contribution of DCs to viral pathogenesis.
Immunomodulation of DCs by HIV infection.
Modulation of DCs by HIV infection -particularly modulation of, or interference with, the antigen-presenting function of DCs -is a key aspect of viral pathogenesis and contributes to viral evasion of immunity. Compared with DCs from healthy donors, DCs taken from the peripheral blood of HIV-infected individuals at different stages of infection are significantly less efficient at stimulating allogeneic T cells 59, 60 . It has been reported that DC-SIGN + DCs from individuals with acute HIV infection have reduced expression of the co-stimulatory molecules CD80 and CD86, and this might influence DC-induced T-cell responses 61 . Consistent with this finding, HIV-infected MDDCs 62 and myeloid DCs 63 fail to mature in culture and can stimulate T cells to produce the regulatory cytokine IL-10, thereby promoting an immunosuppressive response 62 . These results indicate that productive HIV infection of myeloid DCs undermines the direct induction of T-cell-mediated immunity. By contrast, some studies have indicated that MDDCs from HIV-infected individuals can efficiently induce cytotoxic T lymphocytes (which are CD8 + ) to respond to various antigens 64, 65 , suggesting that modulation of expression of co-stimulatory molecules by HIV-infected DCs might not necessarily subvert the priming of cytotoxic T lymphocytes by DCs. In addition, Smed-Sorensen et al. 33 did not observe functional defects in cytokine production following stimulation of HIV-infected myeloid DCs and pDCs.
The regulatory and accessory proteins of HIV, such as Nef (negative factor) and Tat (transcriptional transactivator), have been reported to have various effects on immature DCs, although again the findings are not always consistent. Messmer and colleagues 66 reported that expression of adenovirus-vector-encoded Nef by immature MDDCs triggers the production of various chemokines and other cytokines, and stimulates activation of T cells, but these processes occur in the absence of upregulation of expression of DC maturation markers. Similarly, HIV infection or expression of adenovirus-vector-encoded Tat by immature DCs can induce IFN-responsive gene expression without inducing DC maturation 67 . By contrast, exposure to recombinant (Escherichia coli-expressed) Nef or Tat protein led to efficient DC maturation, including upregulation of expression of DC maturation markers 68, 69 . Tat might have a role in viral pathogenesis, through inducing the production of T-cell and macrophage chemoattractants by immature DCs, and thereby might facilitate the spread of HIV infection 67 . Finally, Nef can downregulate the expression of CD1a and MHC class I molecules by immature MDDCs 70, 71 , possibly impairing antigen presentation and contributing to immune evasion by HIV. 
Cis-infection
HIV infection of permissive cells through viral-receptormediated entry, resulting in the production of progeny viruses. HIV transmission to target cells can be mediated after infection of dendritic cells.
Macropinocytosis
An actin-dependent process by which cells engulf large volumes of fluid.
DCs transmit HIV to CD4 + T cells Using simian immunodeficiency virus and a rhesus macaque model of intravaginal transmission, several studies have indicated that simian immunodeficiency virus can rapidly penetrate the vaginal mucosa and then infects or associates with intraepithelial DCs, which can transmit virus to CD4 + T cells [72] [73] [74] . In one study of human cervical explants exposed to HIV, it was shown that migratory DC populations from the cervical tissue account for 90% of HIV dissemination 75 . The results from both of these studies indicate that DCs might have an important role in HIV transmission at mucosal surfaces 2, 3 . Langerhans cells in the mucosal epithelium have been proposed to be the initial target of HIV during infection by sexual transmission 21 , although this remains controversial. In addition to these Langerhans cells and immature DCs in the subepithelial mucosae, CD4 + CCR5
+ T cells and macrophages that reside in the subepithelium might also be early targets of HIV infection and transmission in vivo (reviewed in REFS 2,76) (FIG. 1) .
The transfer of HIV from DCs to CD4 + T cells involves three discrete steps. First, DCs capture and bind HIV. Second, HIV then traffics within the DCs. Third, it is transferred to CD4 + T cells by a process that is known as trans-infection. In the following section, we consider HIV trans-infection mediated by DCs that are not themselves infected. In a later section, we discuss the transfer of progeny (newly synthesized) virus from infected DCs to CD4 + T cells, known as
Capture of HIV by DCs. DCs have a unique membranetransport pathway that facilitates the uptake of pathogens for the initiation of adaptive immune responses. DCs constitutively take up extracellular fluid by macropinocytosis, and they engulf antigens and whole pathogens by endocytosis and phagocytosis mediated by Fc receptors and C-type lectins (such as DC-SIGN) 16, 44, 53 . C-type lectins are the main HIV attachment factors that are expressed by dermal and mucosal DCs. Four types of C-type lectin can bind HIV gp120: DC-SIGN, langerin, the mannose receptor (also known as CD206) and an unidentified trypsin-resistant C-type lectin 36, 56 . No single C-type lectin is fully responsible for the binding of HIV to all DC subsets. The binding of gp120 to DCs that migrate from the tonsils seems to depend on CD4. By contrast, HIV capture by Langerhans cells is partly mediated by langerin 56 . For DC-SIGNdependent HIV binding, interactions between gp120 and the carbohydrate-recognition domain of DC-SIGN are required for HIV capture 77, 78 
DC-SIGN-mediated HIV transmission seems to require steps beyond simple binding and sequestration of virus 79, 80 , indicating that the binding and the transfer functions of DC-SIGN can be dissociated. So, despite identification of endogenous expression of DC-SIGN or other C-type lectins by several cell types in vivo, these cells might not be able to support HIV trans-infection. The expression of DC-SIGN has been shown to increase direct HIV infection of DC-SIGN-transfected cells 81, 82 , but it might inhibit HIV-envelope-mediated cell-cell fusion 83 , indicating that competition between CD4 and figure) with the HIV envelope glycoprotein gp120 is required for the binding of HIV to DC-SIGN 77 .
Interactions of the carbohydrate-recognition domain with HIV depend on the high proportion of high-mannose oligosaccharides in HIV envelope glycoproteins 78, 123, 124 . DC-SIGN functions as a tetramer (see figure) . This multimerization depends on repeated sequences in the repeat domain of DC-SIGN, which is present extracellularly and stabilizes tetramers of DC-SIGN and increases ligand-binding avidity 123, 125 . The cytoplasmic domain of DC-SIGN contains three defined internalization motifs: a di-leucine-based motif, a tri-acidic (Glu-Glu-Glu) cluster and a tyrosine-based motif. These motifs might contribute to DC-SIGN-mediated internalization of HIV 53, 124 . DC-SIGN-bound HIV can enter cells by endocytosis. Some viruses might escape degradation in endolysosomal compartments and usurp endosomal trafficking by being transmitted to CD4 + T cells, resulting in productive HIV trans-infection 10, 94 . DC-SIGN facilitates the uptake of viral antigens for MHC-class-I-and MHC-class-IIrestricted antigen presentation, leading to activation of virus-specific CD8 + and CD4 + T cells, respectively 42, 114 . The HIV protein Nef (negative factor) can upregulate the expression of DC-SIGN by DCs and increases the clustering of DCs with T cells, thereby promoting HIV trans-infection DC-SIGN for binding gp120 probably affects both access of the virus to the cytosol and formation of syncytia.
Transfer of captured HIV by DCs.
A molecular clue to the process of DC-mediated HIV transmission was provided by studies of DC-SIGN-expressing cells 53, 77 . A subset of cells in human blood (0.01% of total peripheralblood mononuclear cells) was isolated on the basis of co-expression of DC-SIGN and the monocyte marker CD14; these DC-like cells were reported to be able to increase HIV trans-infection of CD4 + T cells in comparison to CD14 + monocytes and CD14 -peripheral-blood DCs 84 . Notably, DC-SIGN + cells that were isolated from the rectal mucosa and that seemed to have an immature DC phenotype could efficiently bind and transfer HIV to CD4 + T cells 85 . These DC-SIGN + cells constitute only 1-5% of total mucosal mononuclear cells, but they were shown to be responsible for more than 90% of HIV binding. . The high level of DC-SIGN that is expressed by macrophages in the lymphoid tissues or in the blood indicates that DC-SIGN might aid in HIV trans-infection by macrophages in vivo 58, 81, 90, 91 ; however, this has yet to be confirmed. Notably, similar to MDDCs, human monocyte-derived macrophages transmit HIV in a DC-SIGN-independent manner 92, 93 , possibly involving other C-type lectins, such as the mannose receptor.
The trafficking of HIV in DCs seems to be a crucial step in viral transmission and might also be DC-SIGN independent. Kwon and colleagues 94 observed that HIV that was internalized after binding DC-SIGN retained its infectivity and could be transmitted to target CD4 + T cells. DC-SIGN mediates rapid internalization of intact HIV into a non-lysosomal compartment that has a low pH 94 . However, it is not clear whether internalized HIV virions continue to associate with DC-SIGN or whether DC-SIGN mediates recycling of intact virus back to the cell surface. The precise intracellular trafficking and localization of internalized HIV within DCs remains to be elucidated.
DC-SIGN-mediated HIV transmission is cell-type dependent 80, 82, 95 and requires cell-cell contact 80 . Interestingly, B-cell transfectants that express DC-SIGN mediate HIV trans-infection as efficiently as DCs, whereas monocyte transfectants do not 95 . In related studies, we observed that co-cultures of different cell types might interfere with DC-SIGN-mediated HIV transinfection 80 . These findings reinforce the idea that the cellular environment is an important consideration when examining transmission of HIV that has been captured by DC-SIGN or other viral attachment factors.
Despite the detection of DC-SIGN expression by DCs in various human tissues 53, 58, 61, 85, 90, [96] [97] [98] , none of the DC subsets in vivo (myeloid DCs, pDCs and Langerhans cells) has been clearly shown to express DC-SIGN 31, 36, 53, 56, 58, 99 , indicating that the role of DC-SIGN in DC-mediated HIV transmission might be more limited in vivo than it is in vitro. Some submucosal DC populations at sites of initial HIV infection express DC-SIGN and seem to interact with HIV efficiently in vitro 56, 85, 97 . However, given that they reside beneath the mucosal epithelium, DC-SIGN (TABLE 2) .
Immunological synapse
A junctional structure that is formed between an antigenpresenting cell and a T cell. Important molecules involved in T-cell activation -including the T-cell receptor, signaltransduction molecules and molecular adaptorsaccumulate in an orderly manner at this site. Mobilization of the actin cytoskeleton is required for formation of the immunological synapse.
The efficiency of HIV transmission can be increased by maturation of DCs 8, 28, 55, 100 , indicating that mature DCs in the lymphoid tissues might facilitate the infection of lymphoid-tissue-resident CD4 + T cells. However, the mechanisms that underlie this increase in viral transmission have not been well defined. Downmodulation of the uptake and degradation of antigen in mature DCs, as well as more-efficient interactions between mature DCs and T cells, might contribute to the increase in the efficiency of HIV transmission 8, 55 . Depending on the activating signals that immature DCs receive, they can develop into different subsets of mature DCs, with differing capabilities of HIV transmission and T-cell activation 55 (FIG. 2 ). An increase in the expression of ICAM1 correlates with the increased viral transmission by mature DC subsets, possibly owing to stronger DC-T-cell interactions through ICAM1 binding to T-cell-expressed LFA1 (lymphocyte function-associated molecule 1) 55 . Moreover, differences in the cellular trafficking of HIV within immature DCs and mature DCs might also contribute to differences in the potential to transmit HIV (L.W. and V.N.K., unpublished observations). Consistent with this, mature DCs have been reported to contain large numbers of intact virions in large vesicular compartments that have a perinuclear localization, whereas immature DCs retain small numbers of intact virions in endosomes close to the plasma membrane 12, 101 . DC maturation is associated with a reduced ability to support HIV replication, being 10-100-fold lower in mature DCs than in immature DCs 28, 102 (TABLE 2) . But HIV-pulsed mature DCs have been shown to contain 15-fold more viral DNA than immature DCs, initially indicating that viral entry was not impaired 102 . However, a recent study indicated that the defect in HIV replication that is observed for mature DCs results at least partially from decreased viral fusion 103 . After analysing the phases of viral replication, Bakri et al. 104 reported that DC maturation does not affect reverse transcription, nuclear import and integration of HIV cDNA, indicating that the reduced viral replication that is observed for mature DCs is due to post-integration blocks at the transcriptional level. This might account for why large amounts of viral DNA are detected in mature DCs, yet mature DCs do not efficiently release virions.
Mechanisms of DC-mediated HIV transmission
The current evidence indicates that DC-mediated HIV infection can occur by several distinct processes that can take place concurrently. These processes include transinfection involving infectious synapses or exosomes, as well as cis-infection following de novo viral production in DCs (FIG. 3) .
HIV trans-infection through infectious synapses. Initial studies using MDDCs indicated that cell-cell contact is required for efficient CD4 + T-cell infection 105 . More recently, studies have revealed that HIV transmission can occur across the infectious synapse 8, 9, 12, 106 . The structure of the infectious synapse might have similarities to the immunological synapse, which is formed between antigen-presenting cell and T-cell conjugates 107 . The set of cell-surface molecules that contributes to the infectious synapse and potentially supports the transfer of HIV from DCs to CD4 + T cells has not been fully identified. HIV itself and HIV receptors are found concentrated at the infectious synapse, and DC-SIGN molecules are also detected at the infectious synapse 8, 9, 106 ; however, it is unclear whether these molecules (HIV receptors and DC-SIGN) or any other molecules are essential to promote formation of the infectious synapse. Interestingly, suppression of DC-SIGN expression has been shown to impair formation of the infectious synapse and to inhibit trans-infection of CD4 + T cells with X4 HIV strains 9, 108 . We have reported that cells that transfer HIV do not need to express MHC class II molecules for efficient DC-SIGN-mediated HIV transmission 80 , indicating that viral transmission to CD4 + T cells can occur in the absence of the classically defined immunological synapse. Indeed, human fibroblast or epithelial cell lines that express HIV receptors can be effective target cells for DC-or DC-SIGN-mediated HIV transmission 77, 87, 94 . And an earlier study has shown that even DCs from mice (which cannot be infected with HIV) can transmit HIV to human CD4 + T cells 6 . These results indicate that donor-and target-cell requirements for formation of the infectious synapse are minimal or that other pathways of HIV transmission are used by these cell types. Under conditions in which there is a large inoculum of virus and in which cells are placed in T-cell co-cultures soon after exposure to HIV, it is likely that infectioussynapse-mediated HIV transfer is responsible for most of the rapid and efficient viral transfer between DCs and CD4 + T cells in vitro. However, in vivo, it is probable that different mechanisms of transmission also contribute or even are dominant.
HIV trans-infection through exosomes. Wiley and Gummuluru 10 recently showed that DC-derived exosomes can mediate HIV trans-infection. HIV that is captured by immature MDDCs is rapidly internalized into endosomal multivesicular bodies, which are endocytic bodies that are enriched in tetraspanins. Intriguingly, some of the endocytosed HIV virions are constitutively released into the extracellular milieu associated with endocytic vesicles 10 that are known as exosomes 109 , and these exosomes might fuse with target-cell membranes to deliver infectious virus. The infectious virus that is associated with cell-free exosomes is only part of the total virus that can be measured during synaptic transmission. However, exosomes might provide a pathway by which intracellular virus reaches the infectious synapse, but this remains to be formally proved. The remaining HIV that is resident in multivesicular bodies in DCs might enter the lysosomal pathway and be degraded 10 . Therefore, the exosome-release pathway might enable HIV to circumvent immune destruction after capture by DCs. Although further study is required, it is intriguing to note that the exosome-associated HIV particles that are released from immature MDDCs have been reported to be 10-fold more infectious than cell-free viruses on a per-particle basis 10 . Similar to immature MDDCs, HIV trafficking to the infectious synapse between mature MDDCs and CD4 + T cells also involves a tetraspaninsorting pathway 106 . Therefore, it is conceivable that HIV also exploits the exosome-release pathway of mature DCs to facilitate viral transmission and immune evasion.
In productively infected macrophages, exocytosis and exosome-trafficking pathways might also be used for HIV virion assembly and release [110] [111] [112] . It will be interesting to determine whether, in vivo, myeloid DC, pDC and Langerhans-cell subsets also use the exosomerelease pathway to promote HIV trans-infection. The relative importance of this pathway of trans-infection in comparison to the infectious-synapse-mediated pathway remains to be established.
HIV infection results in viral transmission in cis.
Although direct HIV infection of DCs is less efficient than infection of CD4 + T cells 28, 102 , an increasing amount of evidence indicates that long-term HIV transmission that is mediated by DCs depends on viral production by the DCs. It has been reported that immature DCs and some DC-SIGN-expressing cell lines can retain infectious virus for up to 6 days after exposure to HIV 77, 82, 113 . However, recent studies have indicated that, in MDDCs, most incoming virus is degraded within 24 hours 12, 42, 114 . Therefore, after 24 hours, virus that is transmitted from DCs to CD4 + T cells must be progeny virus. So there might be two phases of DC-mediated HIV transfer to CD4 + T cells 12 : the first phase (within 24 hours of exposure to HIV) might involve trafficking of captured virus from the endolysosomal pathway to the DC-T-cell synapse; the second phase (24-72 hours after viral exposure) would involve de novo replication of virus in DCs. It should be pointed out that these two processes are not necessarily sequential or interdependent. Other recent findings also support the idea that HIV replication in DCs is required for long-term viral transmission 13, 15 . Nobile and colleagues 13 reported that transfer of incoming virions by immature MDDCs or DC-SIGN-expressing cells occurs only within a few hours of viral exposure, indicating that there is no long-term storage of the original infectious HIV virions in these cells. However, several days after viral exposure, progeny virions can also be transmitted to CD4 + T cells by infected DCs 13 . Similar to these studies with MDDCs, Lore and colleagues 14 reported that, soon after exposure to HIV, pDCs and myeloid DCs from human blood can transfer the virus to CD4 + T cells in the absence of a productive infection. However, after a productive infection has been established in the DCs, it is mainly progeny virus that spreads to CD4 + T cells 14 . These results indicate that HIV-infected DCs in vivo might function as viral reservoirs during migration to the lymphoid tissues, thereby helping to spread viral infection.
Both phases are likely to contribute to the in vivo transfer of HIV from DCs to CD4 + T cells; however, given the low levels of HIV replication in DCs and the low frequency of DCs in vivo, the importance of DCmediated transmission of de novo-synthesized virus in vivo remains to be examined. Our results using replication-defective, single-cycle reporter HIV in vitro indicate that viral transmission can occur efficiently in the absence of viral replication 8, 80, 86, 87, 95 . So the low-level replication of HIV in DCs might not be necessary to facilitate viral dissemination if rapid viral transfer has already occurred through infectious synapses.
Future directions
In opposition to the immune sentinel function of DCs to capture and present processed antigens from pathogens, HIV 'hijacks' DCs to promote viral dissemination efficiently. Elucidating the interactions of HIV with DCs will be vital for uncovering the contribution of DCs to the pathogenesis of HIV. An improved understanding of DC biology might also facilitate studies of the interactions of DCs with HIV and other human pathogens. It will be crucial to dissect and compare the viral-antigen processing and presentation pathways in HIV-infected DCs and in DCs that have internalized virions. In addition, the type and tissue source of DCs from humans and non-human primates will be an important consideration in these analyses. Also, because CD4 + T-cell populations in the gastrointestinal tract suffer the most marked depletion in both the acute and the chronic stage of HIV infection 115, 116 , it will be important to characterize DC populations in the gastrointestinal tract for their susceptibility to HIV infection and for their ability to promote viral transmission to CD4 + T cells in the gut mucosae.
Viral assembly and budding from infected DCs is a poorly understood area of HIV research that also requires further study. An early study reported that new HIV virions could bud from the surface of infected MDDCs 27 , although this was a rare finding. In infected macrophages, multivesicular-body-like compartments seem to be important for viral assembly and budding 110, 111, 117 , but in infected DCs, the involvement of these compartments remains to be proved.
In this Review, we have focused on the role of DCs in the dissemination of HIV and how HIV might hijack the functions of DCs to its advantage. DCs are, however, well known to be potent stimulators of immune responses and therefore have been used in prophylactic and therapeutic approaches for individuals who are infected with HIV. For example, transfer of autologous MDDCs loaded with whole HIV that had been inactivated was shown to suppress viral load in individuals who are chronically infected with HIV 118 . By contrast, a pilot clinical trial using DCs pulsed with HIV-derived peptide did not show significant therapeutic effects in six HIV-infected patients 119 . So further investigation of the antiviral immune responses induced by inactivated-HIV-loaded DCs will be crucial to understand the correlates that underlie the observed therapeutic effects.
